MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 197 filers reported holding MYRIAD GENETICS INC in Q1 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,244,000 | -87.7% | 62,922 | -91.9% | 0.01% | -89.5% |
| Q3 2020 | $10,099,000 | +588.4% | 774,489 | +498.6% | 0.10% | +556.2% |
| Q2 2020 | $1,467,000 | -13.9% | 129,373 | +96.3% | 0.02% | -55.6% |
| Q2 2017 | $1,703,000 | -69.0% | 65,900 | -76.9% | 0.04% | -67.6% |
| Q1 2017 | $5,488,000 | +48.5% | 285,830 | +29.0% | 0.11% | +56.3% |
| Q4 2016 | $3,695,000 | -60.4% | 221,630 | -51.1% | 0.07% | -57.5% |
| Q3 2016 | $9,336,000 | – | 453,626 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
| PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
| Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
| Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
| EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
| Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
| Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
| AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
| Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |